Long-term myocardial effects of noninvasive ventilation in patients with obesity hypoventilation syndrome.

Respir Med

Department of Respiratory Medicine and Tuberculosis, P.J. Safarik University, Faculty of Medicine, and L. Pasteur University Hospital, Kosice, Slovakia. Electronic address:

Published: September 2024

AI Article Synopsis

  • The study investigates the long-term effects of BiPAP therapy on heart function in patients with obesity hypoventilation syndrome (OHS), as these effects are not well understood.
  • Thirteen patients participated, and after 3 and 12 months of BiPAP treatment, significant improvements in heart metrics like stroke volume and ejection time were observed, alongside reduced levels of inflammatory markers.
  • Overall, the results indicate that BiPAP therapy can enhance cardiac function and decrease inflammation in patients with chronic OHS over a year of treatment.

Article Abstract

Introduction: Chronic effects of noninvasive ventilation on myocardial function in patients with obesity hypoventilation syndrome (OHS) are scarcely understood. The aim of the present study was to evaluate the long-term effects of volume-targeted bilevel positive airway pressure ventilation (BiPAP) on cardiac parameters and myocardial biomarkers in patients with OHS.

Methods: Clinically stable patients with OHS referred to the tertiary center for the initiation of long-term BiPAP therapy were consecutively enrolled. At baseline, all participants underwent overnight cardiorespiratory polygraphy. BiPAP therapy using volume-targeted spontaneous/timed mode delivered via an oro-nasal mask was initiated. Beat-to-beat noninvasive monitoring by impedance cardiography was used to assess heart function at baseline and after 3 and 12 months of BiPAP use. Serum troponin 1, N-Terminal Pro-B-Type Natriuretic Peptide (NT-ProBNP), tumor necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6) were monitored.

Results: Thirteen patients (10 men; mean age, 55.8 ± 9.8 years; mean body mass index of 47.8 ± 5.9 kg/m) were recruited. From baseline to 3, and to 12 months of BiPAP use, left ventricular stroke volume (SV), ejection time (LVET), and ejection time index significantly increased (P = 0.030; P < 0.001; P = 0.003, respectively), while heart rate and systolic time ratio significantly decreased (P = 0.004; P = 0.034, respectively). Reductions in serum NT-proBNP, IL-6 and TNF-α were observed (P = 0.045; P = 0.018; P = 0.003, respectively). No significant changes in serum troponin were detected throughout the study.

Conclusions: The present findings of increased SV, in association with lengthening of LVET, reductions of NT-proBNP and reductions in circulatory inflammatory markers in patients with stable OHS and chronic moderate-to-severe daytime hypercapnia treated with BiPAP over 1 year support the role of this therapeutic mode in such patients.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rmed.2024.107735DOI Listing

Publication Analysis

Top Keywords

effects noninvasive
8
noninvasive ventilation
8
patients obesity
8
obesity hypoventilation
8
hypoventilation syndrome
8
bipap therapy
8
baseline months
8
months bipap
8
ejection time
8
patients
5

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!